期刊文献+

应用蛋白质组学技术在人肾癌组织中发现2个特异性生物标志物 被引量:4

Detection of two specific biomarkers in humen kidney cancer tissue using proteom ic profiling technology
原文传递
导出
摘要 目的探讨人肾肿瘤组织和正常肾组织之间蛋白质的差异表达,寻找特异性生物标记物。方法应用蛋白质组学(SELDI)技术,检测12例人肾肿瘤和正常肾组织蛋白质谱图表达。结果与正常肾组织比较,在IMAC3蛋白质芯片上人肾肿瘤组织谱图中显示2个特异性蛋白质峰明显增高,相对分子质量依次为5750.4和5861.7,其特异性和敏感性高。结论人肾肿瘤组织中特异性蛋白质的发现,对进一步研究肿瘤发生机理及其临床特异性生物标志物的检测等具有重要意义。 Objective To explore the different expression of protein between human kidney cancer and normal kidney tissues and to identify specific biomarkers. Methods The protein spectra of 12 samples from human kidney cancer patients and another 12 samples taken from the normal renal tissues which were distal to the renal cancer were analyzed by SELDI (Surfaced enhanced laser desorption/ionization) technology. Results Compared with normal kidney tissues, two specific protein peaks with molecular weight of 5750.4 Da and 5861.7 Da respectively of the protein spectra in human kidney cancer on IMAC3 protein chip elevated significantly with high specificity and sensitivity. Conclusions Detection of specific protein in human kidney cancer is significant both for study on cancer development mechanism and determination of clinical specific biomarkers.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2005年第9期585-587,共3页 Chinese Journal of Urology
基金 国家自然科学基金资助项目(30371325) 中国博士后科学基金资助项目(2003033455)
  • 相关文献

参考文献9

二级参考文献43

  • 1J.萨姆布鲁克等 金冬雁等(译).质粒DNA的分离与纯化.分子克隆实验指南,第2版[M].北京:科学出版社,1996.19-24.
  • 2Smith R A, Mettlin C S, Davis K J, et al. American cancer society guidelines for the early detection of cancer. CA Cancer J Clin, 2000, 50(1): 34 -49.
  • 3Bichsel V E, Liotta L A, Petricoin E F, et al. Cancer proteomics: from biomarker discovery to signal pathway profiling.Cancer J, 2001, 7(1): 69 - 78.
  • 4Eggeling F V, Junker K, Fiedler W, et al. Mass spectrometry meets chip technology: A new proteomic tool in cancer research?Electrophoresis, 2001, 22:2898 - 2902.
  • 5Eggeling F V, Davies H, Lomas L, et al. Tissue-specific microdissection coupled with Protein Chip array technologies:applications in cancer research. Biotechniques, 2000, 29(5): 1066 - 1070.
  • 6Paweletz C, Trock B, Pennanen M, et al. Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer. Dis Marker, 2001, 17(4): 301 - 307.
  • 7Vlahou A, Schellhammer P F, Mendrinos S, et al. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. American Journal of Pathology, 2001, 158(4): 1491 - 1502.
  • 8Petricoin E F, Ardekani A M, Hitt B A, et al. Use of proteomic patterns in serum to identify ovarian cancer. The Lancet, 2002,359:572 - 577.
  • 9Shibata Y, Haruki N, Kuwabara Y, et al. Expression of PTTGI (pituitary tumor transforming gene) in esophageal cancer. Jpn J Clin Oncol, 2002, 32(7): 233-237.
  • 10Pei L. Identification of c-myc as a down-stream target for pituitary tumor-transforming gene. J Biol Chem, 2001, 276(11):8484-8491.

共引文献71

同被引文献36

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部